FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
EUCROF Paediatric Training: Our CEO’s Vision for Advancing Paediatric Clinical Research
In the ever-advancing world of clinical research, staying at the forefront of knowledge and practices is imperative. On 12 September 2023, our [...]
Developed tools for Rare Diseases researchers – ERICA & EJP RD Joint Conference
Bonka Georgieva, CVBF's Project Manager, presented at the "ERICA & EJP RD Joint Conference" held in Amsterdam. The event served as a [...]
XVI Foresight Training Course
Arianna Bertolani, our Head of Project and Development, will participate, as a speaker at the 16th Foresight Training Course entitled "Repurposing to [...]
CVBF is about to start a project to speed up and facilitate the diagnosis of celiac disease
The consortium consisting of IRCCS Materno Infantile “Burlo Garofolo” (Project Leader), Azienda Ospedaliera Universitaria Federico II, Azienda ULSS2 Marca Trevigiana [...]
Survey: International Clinical Trials Registry Platform (ICTRP) search portal user experience
In order to improve the user experience of the International Clinical Trials Registry Platform (ICTRP) search portal, the World Health [...]
CVBF spotlight on scientific literature: “Why children have to wait years for new drugs”
This recent article is part of Nature Outlook: Children‘s health and focuses on the lack of medicines approved for paediatric [...]
First gene therapy to treat haemophilia B
EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Hemgenix (etranacogene dezaparvovec), the the first [...]
Share4Brain Project’s meeting in Athens
The Share4Brain Project meeting was held on 23-24 of September 2021 at Amarilla hotel in Athens, Greece. Greek policymakers such as MEP Stelios Kymporopoulos, the member of [...]
NeoVanc Project Article published in the LANCET Child & Adolescent Health Journal
The NeoVanc Project article Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial was published in the Lancet Child [...]
Kids suffer serious adverse reactions in AGTC gene therapy trial
Applied Genetic Technologies Corporation has run into safety problems after escalating the dose in its paediatric gene therapy trial. Sixty percent of subjects in the [...]
My Clinical Trial Center serious videogame
The iCAN groups KIDS Albania and KIDS Bari, with the support of CVBF and TEDDY Network, have created a brand-new serious game: My Clinical Trial Center (My [...]
Newsletter, MAY 2021
31st May 2021 Newsletter May 2021 CVBF CRO Services designed for your Clinical Trial! CVBF is a self-certified Contract Research Organisation (CRO) at [...]
Newsletter, MARCH 2021
30th March 2021 Newsletter March 2021 The recent approval by regulatory agencies worldwide of Zolgensma, a gene therapy for children with type 1 Spinal [...]